It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The goal of the current study was to develop an asymmetric guided bone regeneration (GBR) membrane benefiting from curcumin and aspirin. The membrane was prepared using electrospinning technique and then was physic-chemically characterized by the conventional methods. The release profile of aspirin from the prepared membrane was also measured by ultraviolet spectrophotometry. Also, the antibacterial activities of the membrane was evaluated. We also assessed the in vitro effects of the prepared membrane on the biocompatibility and osteogenic differentiation of dental pulp stem cells (DPSCs), and evaluated in vivo bone regeneration using the prepared membrane in the defects created in both sides of the dog’s jaw by histology. The results from the characterization specified that the membrane was successfully prepared with monodispersed nanosized fibers, uniform network shaped morphology, negative surface charge and sustained release platform for aspirin. The membrane also showed antimicrobial effects against all tested bacteria. The presence of curcumin and aspirin in the asymmetric membrane enhanced osteogenic potential at both transcriptional and translational levels. The results of the animal test showed that the test area was completely filled with new bone after just 28 days, while the commercial membrane area remained empty. There was also a soft tissue layer above the new bone area in the test side. We suggested that the prepared membrane in this work could be used as a GBR membrane to keep soft tissue from occupying bone defects in GBR surgeries. Besides, the surgeries can be benefited from antibacterial activities and bone healing effects of this novel GBR membrane while, simultaneously, promoting bone regeneration.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Tabriz University of Medical Sciences, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Tabriz, Iran (GRID:grid.412888.f) (ISNI:0000 0001 2174 8913)
2 University of Tabriz, Department of Clinical Sciences, Faculty of Veterinary Medicine, Tabriz, Iran (GRID:grid.412831.d) (ISNI:0000 0001 1172 3536)
3 Tabriz University of Medical Sciences, Infectious and Tropical Diseases Research Center, Tabriz, Iran (GRID:grid.412888.f) (ISNI:0000 0001 2174 8913)
4 Tabriz University of Medical Sciences, Dental and Periodontal Research Center, Tabriz, Iran (GRID:grid.412888.f) (ISNI:0000 0001 2174 8913)
5 Tabriz University of Medical Sciences, Dental and Periodontal Research Center, Tabriz, Iran (GRID:grid.412888.f) (ISNI:0000 0001 2174 8913); Tabriz University of Medical Sciences, Stem Cell Research Center, Tabriz, Iran (GRID:grid.412888.f) (ISNI:0000 0001 2174 8913)